Milestone Pharmaceuticals Inc. (MIST) Tops Q3 EPS by 4c
Tweet
Share
E-mailGet Alerts MIST Hot Sheet
Join SI Premium – FREE
Milestone Pharmaceuticals Inc. (NASDAQ: MIST) reported Q3 EPS of ($0.12), $0.04 better than the analyst estimate of ($0.16).
For earnings history and earnings-related data on Milestone Pharmaceuticals Inc. (MIST) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cantor Fitzgerald Starts Milestone Pharmaceuticals (MIST) at Overweight
- Advance Auto Parts falls on revenue miss, weak guidance
- NACCO Industries (NC) Declares $0.2625 Quarterly Dividend; 2.6% Yield
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
